ebselen has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, C; Wang, J; Wang, P; Yuan, C; Zhao, Y; Zhou, J; Zou, L | 1 |
| Chen, J; Chen, R; Goligorsky, MS; Lu, CY; Moskowitz-Kassai, E; Sanduski, K; Špes, A; Turk, B; Xavier, S | 1 |
1 review(s) available for ebselen and Cardiovascular Diseases
| Article | Year |
|---|---|
Mechanisms of ebselen as a therapeutic and its pharmacology applications.
Topics: Animals; Azoles; Bipolar Disorder; Cardiovascular Diseases; Hearing Loss, Sensorineural; Humans; Immune System Diseases; Isoindoles; Neurodegenerative Diseases; Organoselenium Compounds; Stroke | 2020 |
1 other study(ies) available for ebselen and Cardiovascular Diseases
| Article | Year |
|---|---|
Cathepsin cleavage of sirtuin 1 in endothelial progenitor cells mediates stress-induced premature senescence.
Topics: Animals; Apoptosis; Arginine; Autophagy; Azoles; Cardiovascular Diseases; Cathepsins; Cell Membrane Permeability; Cells, Cultured; Cellular Senescence; Collagen Type I; Down-Regulation; Endothelial Cells; Endothelium, Vascular; Hydrogen Peroxide; Isoindoles; Lysosomes; Mice; Mice, Knockout; Mice, Transgenic; Organoselenium Compounds; Recombinant Proteins; Risk Factors; Sirtuin 1; Stem Cells; Stress, Physiological | 2012 |